サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1425798

自己注射の世界市場レポート 2024年

Self-Injections Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
自己注射の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

自己注射の市場規模は、近年急激に拡大しています。2023年の507億2,000万米ドルから、2024年には635億4,000万米ドルへと、CAGR25.3％で拡大すると予測されています。過去実績期間の成長は、慢性疾患の増加、患者のエンパワーメントの強化、支援的な規制、在宅医療オプションへの選好、ヘルスケアソリューションにおける費用対効果の重視など、さまざまな要因によるものです。

また、テレヘルスと遠隔医療の成長も自己注射市場の拡大に寄与しています。遠隔医療は、遠隔地から様々なヘルスケアサービスを提供するための通信技術の利用を含み、遠隔医療は特に遠隔地からの臨床診察とヘルスケア提供に焦点を当てています。これらのデジタルヘルスプラットフォームは、バーチャルコンサルテーションを可能にし、医療提供者が遠隔で自己注射を処方できるようにする上で重要な役割を果たしています。患者は、仮想トレーニングセッションから恩恵を受け、自己注射の適切な投与を保証します。遠隔医療は、患者の服薬アドヒアランスのリアルタイムモニタリング、継続的な疾病管理、薬物送達のための遠隔薬局サービスへの便利なアクセスを容易にします。米国疾病予防管理センター（CDC）の報告によると、米国の成人の37.0％が過去12カ月以内に遠隔医療を利用しており、遠隔医療の採用は2021年に大幅に増加しました。遠隔医療が提供する利便性とアクセシビリティは、自己注射市場の成長に大きく寄与しています。

北米は、2023年の自己注射市場において最大の地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。自己注射市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の自己注射市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の自己注射市場規模実績と成長、2018年～2023年
  • 世界の自己注射市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の自己注射市場、タイプ別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • デバイス
  • 製剤
  • 世界の自己注射市場、投与経路別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 表皮
  • 循環器または筋骨格系
  • 臓器
  • 中枢神経系
  • 世界の自己注射市場、用量別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 単回投与
  • 複数回投与
  • 世界の自己注射市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 自己免疫疾患
  • ホルモン障害
  • 腫瘍学
  • 孤児の病気
  • 疼痛管理
  • 呼吸療法
  • その他の用途
  • 世界の自己注射市場、流通チャネル別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 病院薬局
  • クリニック
  • 化学者
  • オンライン薬局

第7章 地域と国の分析

  • 世界の自己注射市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の自己注射市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 自己注射市場の競合情勢
  • 自己注射市場の企業プロファイル
    • AbbVie Inc.
    • Antares Pharma Inc.
    • Baxter International Inc.
    • Bayer AG
    • Becton Dickinson and Company

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r13029

Self-Injections Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The self-injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Devices; Formulations
  • 2) By Route Of Administration: Skin; Circulatory or Musculoskeletal; Organs; Central Nervous System
  • 3) By Dosage: Single Dose; Multi Dose
  • 4) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 5) By Distribution Channel: Hospitals Pharmacies; Clinics; Chemist; Online Pharmacies
  • Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Bayer AG; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Self-injection refers to the act of administering medications or drugs through a device by an individual to themselves without the assistance of a medical professional. This practice allows patients to independently manage their medication regimen.

The primary types of self-injections encompass devices and formulations. These devices enable patients to self-administer medications that require injection without relying on medical professionals. Self-injection devices are utilized for various routes of administration such as skin, circulatory or musculoskeletal systems, organs, and the central nervous system. Dosage types include single-dose and multi-dose, catering to applications in autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. These devices are distributed through various channels including hospitals, pharmacies, clinics, chemists, and online pharmacies.

The self injections market research report is one of a series of new reports from The Business Research Company that provides self injections market statistics, including self injections industry global market size, regional shares, competitors with a self injections market share, detailed self injections market segments, market trends and opportunities, and any further data you may need to thrive in the self injections industry. This self injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-injections market size has grown exponentially in recent years. It will grow from $50.72 billion in 2023 to $63.54 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historical period can be attributed to various factors including the increase in chronic diseases, enhanced patient empowerment, supportive regulations, a preference for home healthcare options, and the focus on cost-effectiveness in healthcare solutions.

The self-injections market size is expected to see exponential growth in the next few years. It will grow to $147.24 billion in 2028 at a compound annual growth rate (CAGR) of 23.4%. The anticipated growth in the upcoming period can be credited to factors like the impact of the pandemic leading to the growth of remote treatment options, expanding into emerging markets, a shift towards patient-centric healthcare services, advantages in drug delivery systems, and the ongoing trend of personalized medicine. Key trends expected in the forecast period encompass the integration of smart technologies, increased usage of biologics, the development of smaller and wearable medical devices, improved safety features, and a higher adoption rate of autoinjectors.

The self-injections market is expected to witness significant growth due to the increasing number of diabetic patients. Diabetes, a condition characterized by inadequate insulin production by the pancreas, affects a substantial population globally. To manage this condition effectively, diabetic patients often use self-injections to administer insulin and other medications, enabling them to control blood sugar levels independently. The International Diabetes Federation (IDF) reported in 2021 that 567 million adults aged 20 to 79 years are currently living with diabetes, and this number is projected to reach 643 million by 2030 and 783 million by 2045. The rising prevalence of diabetes is a key driver propelling the growth of the self-injections market.

The growth of telehealth and telemedicine is also contributing to the expansion of the self-injections market. Telehealth involves the use of telecommunications technology for providing various healthcare services remotely, while telemedicine specifically focuses on remote clinical consultations and healthcare delivery. These digital health platforms play a crucial role in enabling virtual consultations, allowing healthcare providers to remotely prescribe self-injectable medications. Patients benefit from virtual training sessions, ensuring proper administration of self-injections. Telehealth facilitates real-time monitoring of patient adherence, continuous disease management, and convenient access to telepharmacy services for medication delivery. The adoption of telehealth increased significantly in 2021, with 37.0% of adults in the United States utilizing telemedicine within the preceding 12 months, as reported by the Centers for Disease Control and Prevention (CDC). The convenience and accessibility offered by telehealth contribute substantially to the growth of the self-injections market.

Innovation in insulin injection solutions is a key trend in the self-injections market, with major companies focusing on developing new products to gain a competitive edge. For example, in September 2022, Terumo Corporation, a Japan-based medical device company, launched FineGlide, a sterile pen needle designed for patients requiring regular insulin injections or other self-medication. FineGlide prioritizes patient comfort by featuring a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness during injections. The inclusion of Thin Wall Technology improves flow rate and reduces injection force, enhancing the overall experience for patients and promoting drug compliance. This focus on product innovation demonstrates the commitment of major companies to meet the evolving needs of patients in the self-injections market.

Major players in the self-injections market are focusing on the development of smart injecting devices to gain a competitive advantage. In March 2022, Pfizer Inc., a prominent US-based pharmaceutical company, introduced ENBREL SmartClic in Australia. This innovative self-injecting device is designed for patients undergoing treatment with ENBREL, a tumor necrosis factor (TNF) inhibitor prescribed for conditions like Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and Psoriatic Arthritis (PsA). ENBREL SmartClic features an automated, reusable design with user-friendly elements, including a one-button initiation, a larger grip compared to the Enbrel Auto-Injector, and injection speed control. The device is accompanied by a smartphone app, providing additional features such as reminders, injection history recording, site tracking, and streamlined reports. Patients can access these features on their smartphones and share the information with healthcare professionals, enhancing the overall self-injection experience for those dealing with chronic inflammatory diseases.

In June 2022, Dr. Reddy Labs, an India-based pharmaceutical manufacturer, made a significant acquisition by purchasing an injectable portfolio from Eton Pharma for $50 million. This strategic move by Dr. Reddy's aimed to accelerate and expand the availability of affordable medications for patients. The acquisition included new portfolios such as injections and recipes, allowing Dr. Reddy's to diversify its product offerings and strengthen its position in the pharmaceutical market. Eton Pharma, a US-based pharmaceutical manufacturer, contributed to Dr. Reddy's efforts to broaden its pharmaceutical portfolio, signaling a strategic expansion into injectable medications.

Major companies operating in the self-injections market report are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, Scintilla Pharmaceuticals Inc., SHL Group.Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT Ltd., Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.

North America was the largest region in the self injections market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Self-Injections Market Characteristics

3. Self-Injections Market Trends And Strategies

4. Self-Injections Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Self-Injections Market Size and Growth

  • 5.1. Global Self-Injections Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Self-Injections Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Self-Injections Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Self-Injections Market Segmentation

  • 6.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Devices
  • Formulations
  • 6.2. Global Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Skin
  • Circulatory or Musculoskeletal
  • Organs
  • Central Nervous System
  • 6.3. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Dose
  • Multi Dose
  • 6.4. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.5. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals Pharmacies
  • Clinics
  • Chemist
  • Online Pharmacies

7. Self-Injections Market Regional And Country Analysis

  • 7.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Self-Injections Market

  • 8.1. Asia-Pacific Self-Injections Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Self-Injections Market

  • 9.1. China Self-Injections Market Overview
  • 9.2. China Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Self-Injections Market

  • 10.1. India Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Self-Injections Market

  • 11.1. Japan Self-Injections Market Overview
  • 11.2. Japan Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Self-Injections Market

  • 12.1. Australia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Self-Injections Market

  • 13.1. Indonesia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Self-Injections Market

  • 14.1. South Korea Self-Injections Market Overview
  • 14.2. South Korea Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Self-Injections Market

  • 15.1. Western Europe Self-Injections Market Overview
  • 15.2. Western Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Self-Injections Market

  • 16.1. UK Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Self-Injections Market

  • 17.1. Germany Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Self-Injections Market

  • 18.1. France Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Self-Injections Market

  • 19.1. Italy Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Self-Injections Market

  • 20.1. Spain Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Self-Injections Market

  • 21.1. Eastern Europe Self-Injections Market Overview
  • 21.2. Eastern Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Self-Injections Market

  • 22.1. Russia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Self-Injections Market

  • 23.1. North America Self-Injections Market Overview
  • 23.2. North America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Self-Injections Market

  • 24.1. USA Self-Injections Market Overview
  • 24.2. USA Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Self-Injections Market

  • 25.1. Canada Self-Injections Market Overview
  • 25.2. Canada Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Self-Injections Market

  • 26.1. South America Self-Injections Market Overview
  • 26.2. South America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Self-Injections Market

  • 27.1. Brazil Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Self-Injections Market

  • 28.1. Middle East Self-Injections Market Overview
  • 28.2. Middle East Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Self-Injections Market

  • 29.1. Africa Self-Injections Market Overview
  • 29.2. Africa Self-Injections Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Self-Injections Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Self-Injections Market Competitive Landscape And Company Profiles

  • 30.1. Self-Injections Market Competitive Landscape
  • 30.2. Self-Injections Market Company Profiles
    • 30.2.1. AbbVie Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Antares Pharma Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Baxter International Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Self-Injections Market Competitive Benchmarking

32. Global Self-Injections Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Self-Injections Market

34. Self-Injections Market Future Outlook and Potential Analysis

  • 34.1 Self-Injections Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Self-Injections Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Self-Injections Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer